Xencor (XNCR) Total Non-Current Liabilities (2013 - 2026)
Xencor's (XNCR) quarterly Total Non-Current Liabilities came in at $221.1 million in Q1 2026, down 7.86% on a QoQ basis from $239.9 million in Q4 2025.
Xencor (XNCR) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 5 years of Total Non-Current Liabilities data on file, last reported at $221.1 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $221.1 million in Q1 2026; TTM through Mar 2026 was $221.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $239.9 million, down 10.46% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $221.1 million, down from $239.9 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for XNCR reached as high as $267.9 million in Q4 2024 and fell as low as $221.1 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $243.0 million across 3 years, with a median of $239.9 million in 2025.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 10.46% in 2025 and fell as far as 10.46% in 2025.
- Year by year, Total Non-Current Liabilities stood at $267.9 million in 2024, then declined by 10.46% to $239.9 million in 2025, then dropped by 7.86% to $221.1 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $221.1 million in Q1 2026, $239.9 million in Q4 2025, and $267.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 221.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.06 Mn |
| Dec 31, 2025 | 239.91 Mn |
| Dec 31, 2024 | 267.93 Mn |
| Dec 31, 2014 | 8.53 Mn |
| Mar 31, 2013 | -15.10 Mn |